A study presented at the European Congress of Radiology (2–6 March, Vienna, Austria) set out to investigate any procedural or anatomical factors that might affect the technical outcome of prostatic artery embolization.
A study presented at the Symposium on Clinical Oncology (CIO, Hollywood, USA) noted that the hepatitis C virus is a cause of significant morbidity and mortality in the USA. However, the study findings report that treatment regimens have improved in recent years.
Silk Road Medical has been granted CE approval for its Enroute transcarotid neuroprotection system (NPS). The company has also reported the first patients have been treated with the system.
Although systemic thrombolysis achieves similar rates of mortality as catheter-directed intervention for the treatment of acute pulmonary embolism, it also carries “significantly increased odds of intracranial haemorrhagic complications,” according to data presented at the American Venous Forum (AVF; 24–26 February, Orlando, USA).
AngioDynamics has signed an agreement with Merz North America, US affiliates of the global Merz Pharma Group. AngioDynamics is to serve as the exclusive distributor of the Asclera polidocanol injection within the US vein market.
“EVRF (F Care Systems) saphenous ablation is a safe and painless procedure for the treatment of the greater saphenous vein and/or small saphenous vein,” according to recently released data. The authors, led by Attila Szabo, VP-Med Health and Education Centre, Budapest, Hungary, write that “high patient acceptance and minimal postoperative discomfort allows a quick return to work and normal life for patients.”
A few months ago a discussion on the LinkedIn page of the American College of Phlebology caught my attention: “Medicare: maximum four endovenous laser therapies per lifetime?”
According to the World Health Organization, around 300 million people are affected by the pathological oedema of limbs. Lymphoedema is caused by partial or total obstruction of lymphatic collectors as a consequence of skin and deep soft tissue inflammation, trauma of soft tissues and bones, lymphadenectomy and radiation in cancer therapy.
Saphenous pulsation is the cyclical impulse of antegrade flow observed on colour duplex ultrasound after prolonged standing. It is a common observation in patients with saphenous reflux and is detected in the upper part of the great saphenous vein, remote from neighbouring arterial interference. Interest in pulsation has been renewed by its potential as a marker of severe chronic superficial venous insufficiency.
Eximo Medical has successfully completed a multicentre clinical trial for the purpose of obtaining CE approval for marketing in Europe. The results of the trial indicate that use of the Eximo system provides a safe, precise and highly efficacious solution in cases of partial blockage, complete blockage and severe calcification.
Use of dynamic flow reversal when performing transcervical carotid artery stent placement “demonstrated a significant reduction in embolisation to the brain” compared with transfemoral carotid artery stenting using distal filters, according to a Belgian study published in the Journal of Endovascular Therapy.
A study published in the Journal of Endovascular Therapy suggests that carbon dioxide flushing may be a solution for the “potentially underappreciated” problem of arterial air embolism in aortic endografting.
The Surfacer Inside-Out access catheter system (Bluegrass Vascular Technologies) has been successfully used in its first clinical case. The patient in question was facing life-threatening complications from end-stage renal disease.
Halfway through its Controversies, Challenges and Consensus cycle, the Charing Cross Symposium will examine this year the numerous and varied challenges currently facing the vascular and endovascular field. The Symposium will be held from 26 to 29 April 2016 at Olympia Grand, London, UK.
Studies have indicated that patterns of restenosis affect long-term outcomes following retreatment in the superficial femoral artery. Gary Ansel, OhioHealth/Riverside Methodist Hospital, Columbus, USA, presented results at the Leipzig Interventional Course (LINC; 26–29 January 2016, Leipzig, Germany) showing that, when in-stent restenosis occurs, it is more often focal with a drug-eluting stent (Zilver PTX, Cook Medical), whereas it is more diffuse with bare metal stents. The drug-eluting device, according to Ansel, yields less restenosis, less reintervention and reduced plaque burden.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos